Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Journal for ImmunoTherapy of Cancer
Journal
Overview
Identity
Overview
Publication Venue For
Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer
. 10.
2022
Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: Interim results from GARNET - A phase I, single-arm study
. 10.
2022
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: Results from a phase I/II open-label, multicenter study
. 10.
2022
G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes
. 10.
2022
Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis
. 9.
2021
Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model
. 9.
2021
Obesity diminishes response to PD-1-based immunotherapies in renal cancer
. 8.
2020
Impact of body composition on outcomes from anti-PD1 +/-anti-CTLA-4 treatment in melanoma
. 8.
2020
Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) service
. 8:e000992-e000992.
2020
Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study
. 8.
2020
Corrections to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma (Journal for ImmunoTherapy of Cancer (2019) 7 (139) DOI: 10.1186/s40425-019-0621-1)
. 7.
2019
Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma
. 7.
2019
Smoldering myocarditis following immune checkpoint blockade
. 5.
2017
Identity
Electronic International Standard Serial Number (eissn)
2051-1426